Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system

The objective of this study was to observe possible interactions between the renin-angiotensin and nitrergic systems in chronic hypoxia-induced pulmonary hypertension in newborn piglets. Thirteen chronically instrumented newborn piglets (6.3 ± 0.9 days; 2369 ± 491 g) were randomly assigned to receive saline (placebo, P) or the AT1 receptor (AT1-R) blocker L-158,809 (L) during 6 days of hypoxia (FiO2 = 0.12). During hypoxia, pulmonary arterial pressure (Ppa; P < 0.0001), pulmonary vascular resistance (PVR; P < 0.02) and the pulmonary to systemic vascular resistance ratio (PVR/SVR; P < 0.05) were significantly attenuated in the L (N = 7) group compared to the P group (N = 6). Western blot analysis of lung proteins showed a significant decrease of endothelial NOS (eNOS) in both P and L animals, and of AT1-R in P animals during hypoxia compared to normoxic animals (C group, N = 5; P < 0.01 for all groups). AT1-R tended to decrease in L animals. Inducible NOS (iNOS) did not differ among P, L, and C animals and iNOS immunohistochemical staining in macrophages was significantly more intense in L than in P animals (P < 0.01). The vascular endothelium showed moderate or strong eNOS and AT1-R staining. Macrophages and pneumocytes showed moderate or strong iNOS and AT1-R staining, but C animals showed weak iNOS and AT1-R staining. Macrophages of L and P animals showed moderate and weak AT2-R staining, respectively, but the endothelium of all groups only showed weak staining. In conclusion, pulmonary hypertension induced by chronic hypoxia in newborn piglets is partially attenuated by AT1-R blockade. We suggest that AT1-R blockade might act through AT2-R and/or Mas receptors and the nitrergic system in the lungs of hypoxemic newborn piglets.

[1]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[2]  F. Murad,et al.  Immunolocalization of nitric oxide synthase isoforms in human archival and rat tissues, and cultured cells , 2011, Journal of Neuroscience Methods.

[3]  K. Barrington,et al.  Pulmonary hypertension and the asphyxiated newborn. , 2011, The Journal of pediatrics.

[4]  M. Raizada,et al.  ACE2, a promising therapeutic target for pulmonary hypertension , 2011, Current Opinion in Pharmacology.

[5]  Josef M. Penninger,et al.  Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters , 2010, Pharmacology & Therapeutics.

[6]  A. Loeckinger,et al.  Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets , 2010, Critical care medicine.

[7]  A. Ferreira,et al.  Recent advances in the angiotensin‐converting enzyme 2–angiotensin(1–7)–Mas axis , 2008, Experimental physiology.

[8]  E. Bancalari,et al.  The Role of Angiotensin II Receptor-1 Blockade in the Hypoxic Pulmonary Vasoconstriction Response in Newborn Piglets , 2007, Neonatology.

[9]  K. Nakayama,et al.  Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  M. Frid,et al.  Hypoxia-induced Pulmonary Vascular Remodeling Cellular and Molecular Mechanisms Reviews , 2022 .

[11]  D. Tibboel,et al.  Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase , 2006, Cell Biochemistry and Biophysics.

[12]  K. Akimoto,et al.  Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats. , 2005, European journal of pharmacology.

[13]  F. Traganos,et al.  Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[14]  D. Pimentel,et al.  Angiotensin II Differentially Regulates Interleukin-1-β-inducible NO Synthase (iNOS) and Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression , 2004, Journal of Biological Chemistry.

[15]  P. Puri,et al.  Genetic polymorphisms of angiotensin system genes in congenital diaphragmatic hernia associated with persistent pulmonary hypertension. , 2004, Journal of pediatric surgery.

[16]  J. Aschner,et al.  Impaired NO signaling in small pulmonary arteries of chronically hypoxic newborn piglets. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[17]  H. Thai,et al.  Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2 Receptor , 2003, Journal of Pharmacology and Experimental Therapeutics.

[18]  N. Garcia-Cairasco,et al.  Immunohistochemical localization of myosin va in the adult rat brain , 2003, Neuroscience.

[19]  R. Carey,et al.  Angiotensin AT2 Receptors Directly Stimulate Renal Nitric Oxide in Bradykinin B2-Receptor–Null Mice , 2003, Hypertension.

[20]  Thomas Walther,et al.  Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Hallman,et al.  Nitrotyrosine and NO synthases in infants with respiratory failure: Influence of inhaled NO , 2003, Pediatric pulmonology.

[22]  T. Malinski,et al.  Angiotensin II AT1 Receptor Antagonists Inhibit Platelet Adhesion and Aggregation by Nitric Oxide Release , 2002, Hypertension.

[23]  V. Campese,et al.  Losartan Reduces Central and Peripheral Sympathetic Nerve Activity in a Rat Model of Neurogenic Hypertension , 2002, Hypertension.

[24]  T. Jeffery,et al.  Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. , 2001, Pharmacology & therapeutics.

[25]  K. Hahnenkamp,et al.  Selective iNOS Inhibition Prevents Hypotension in Septic Rats While Preserving Endothelium-Dependent Vasodilation , 2001, Anesthesia and analgesia.

[26]  G. Laurent,et al.  Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. , 2000, American journal of respiratory and critical care medicine.

[27]  J. Dubois-Randé,et al.  Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. , 2000, American journal of respiratory cell and molecular biology.

[28]  L. Chimelli,et al.  Microwave-stimulated recovery of myosin-V immunoreactivity from formalin-fixed, paraffin-embedded human CNS , 1999, Journal of Neuroscience Methods.

[29]  G. Hosgood,et al.  Detection and comparison of nitric oxide in clinically normal horses and those with naturally acquired small intestinal strangulation obstruction. , 1999, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[30]  Nadia Smail,et al.  Hypoxemia in the absence of blood loss upregulates iNOS expression and activity in macrophages. , 1999, American journal of physiology. Cell physiology.

[31]  M. Davies,et al.  Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809. , 1998, Surgery.

[32]  G. Semenza,et al.  Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[33]  Lan Zhao,et al.  Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung , 1996, British journal of pharmacology.

[34]  W. Greenlee,et al.  Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. , 1996, Circulation.

[35]  B. Lipworth,et al.  Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. , 1996, Chest.

[36]  N. Morrell,et al.  Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. , 1995, The American journal of physiology.

[37]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[38]  U. K. Laemmli,et al.  Maturation of the head of bacteriophage T4. I. DNA packaging events. , 1973, Journal of molecular biology.

[39]  U. K. Laemmli,et al.  Maturation of the head of bacteriophage T4. II. Head-related, aberrant tau-particles. , 1973, Journal of molecular biology.

[40]  C. Rosenfeld,et al.  Vessel-Specific Regulation of Angiotensin II Receptor Subtypes During Ovine Development , 2005, Pediatric Research.